A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease

Journal of Neuroscience Methods

Volumn 111, Issue 1, 2001, Pages 17-27

  Sun, Anyang ^a   Nguyen, Xuan V ^a   Bing, Guoying ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Fluorescence microscopy; Neuritic plaques; Neurofibrillary tangles; Neuropil threads; Silver staining

Indexed keywords

DIAGNOSTIC AGENT; SOLVENT;

AGED; ALZHEIMER DISEASE; ARTICLE; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HUMAN; INSTRUMENTATION; METHODOLOGY; NERVE CELL; NEUROFIBRILLARY TANGLE; PATHOLOGY; PATHOPHYSIOLOGY; PHOTOCHEMISTRY; SENILE PLAQUE; SILVER STAINING; TEMPORAL LOBE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; FLUORESCENCE; HUMANS; MICROSCOPY, FLUORESCENCE; NEUROFIBRILLARY TANGLES; NEURONS; PHOTOCHEMISTRY; SENILE PLAQUES; SILVER STAINING; SOLVENTS; TEMPORAL LOBE;

EID: 0035888889     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(01)00434-4     Document Type: Article

References (21)

1. Akiyama S, Takahashi S, Ishimori K, Morishima I. Stepwise formation of α-helices during cytochrome c folding. Nat Struct Biol 2000;7:514-20.
2. Braak H, Braak E. The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 1992;15:6-31.
3. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995; 16:271-8.
4. Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common structural unit. Proc Natl Acad Sci USA 1991;88:2288-92.
5. Cullen KM, Halliday GM, Cartwright H, Kril JJ. Improved selectivity and sensitivity in the visualization of neurofibrillary tangles, plaques and neuropil threads. Neurodegeneration 1996;5:177-87.
6. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999;52:1158-65.
7. Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung 1971;19:1-8.
8. Goedert M, Spillantini MG, Jakes R, Crowther RA, Vanmechelen E, Probst A, Gotz J, Burki K, Cohen P. Molecular dissection of the paired helical filament. Neurobiol Aging 1995;16:325-34.
9. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 1996;6:4491-500.
10. Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol 1997;41:17-24.
11. Klunk WE, Xu CJ, Pettegrew JW. NMR identification of the formic acid-modified residue in Alzheimer's amyloid protein. J Neurochem 1994;62:349-54.
12. Kordower JH, Chu Y, Stebbins GT, DeKosky ST, Cochran EJ, Bennett D, Mufson EJ. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001;49:202-13.
13. Low LK, Shin HC, Narayan M, Wedemeyer WJ, Scheraga HA. Acceleration of oxidative folding of bovine pancreatic ribonuclease A by anion-induced stabilization and formation of structured native-like intermediates. FEBS Lett 2000;472:67-72.
14. Luo P, Baldwin RL. Mechanism of helix induction by trifluoroethanol: a framework for extrapolating the helix-forming properties of peptides from trifluoroethanol/water mixtures back to water. Biochemistry 1997;36:8413-21.
15. Markesbery WR. Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S13-9.
16. Martin J, Slade A, Aitken A, Arche R, Virden R. Chemical modification of serine at the active site of penicillin acylase from Kluyvera citrophila. Biochem J 1991;280:659-62.
17. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. Arch Pathol Lab Med 1993;117:132-44.
18. Orlando R, Kenny PT, Zagorski MG. Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions. Biochem Biophys Res Commun 1992;184:686-91.
19. Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM. Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 1994;39:669-73.
20. Probst A, Tolnay M, Langui D, Goedert M, Spillantini MG. Pick's disease: hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol (Berlin) 1996;92:588-96.
21. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. 'Preclinical' AD revisited: neuropathology of cognitively normal older adults. Neurology 2000;55:370-6.